Polymorphisms identified in the upstream core polyadenylation signal of IGF1 gene Exon 6 do not cause pre- and postnatal growth impairment

Autor(es)

Coutinho, Debora C. ; Coletta, Rocio R. D. ; Costa, Elaine M. F. ; Pachi, Paulo R. ; Boguszewski, Margaret C. S. ; Damiani, Durval ; Mendonça, Berenice B. ; Arnhold, Ivo J. P. ; Jorge, Alexander A. L.

• Tipo de documento: Artigo Científico
• Fonte: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM; v. 92, n. 12, p. 4889-4892, Dec. 2007.
• Área do conhecimento: Ciências da Saúde - Medicina
• Assunto(s): Transtornos do crescimento Polimorfismo genético Fator de crescimento insulin-like I Genótipo

Resumo

Few children born small for gestational age (SGA) with IGF1 mutations have been reported. One of these patients presented a mutation at 3' untranslated region (UTR) at exon 6, probably affecting the polyadenylation process. The objective of the study was to sequence the IGF1 gene of children born SGA. IGF1 (exons 1-6) was directly sequenced in 53 SGA children without catch-up growth. Allelic variant frequency of the identified IGF1 polymorphisms was assessed in a total of 145 SGA children and in 180 controls born with adequate weight and length and adult height SD score greater than -2. No mutations were identified in the IGF1 coding regions in SGA children. In contrast, six allelic variants were identified in the upstream core polyadenylation signal located in IGF1 3' UTR at exon 6. The frequency of the different allelic variants was similar in SGA children and controls. It is noteworthy that the same allelic variant, previously described as causing severe IGF1 deficiency, was also observed in homozygous (n = 4) and heterozygous state (n = 6) in normal height controls, corresponding to 4% of studied alleles. The three most frequently identified allelic variants of IGF1 3' UTR showed no effect on height SD score of adult controls as well as on birth characteristics in SGA children. The polymorphisms identified in the upstream core polyadenylation signal at IGF1 exon 6 do not cause IGF1 deficiency as well as pre- and postnatal growth impairment, in contrast to previously reported data. (AU)

• Processo FAPESP: 05/04726-0 - Caracterização molecular das doenças endócrinas congênitas que afetam o crescimento e o desenvolvimento
• Beneficiário: Ana Claudia Latronico Xavier
• Modalidade de apoio: Auxílio à Pesquisa - Temático